Not happy, but holding. On the basis that new management should (eventually) be able to translate increasing revenues (at apparently 38% gross margins) into bottom line profit. It has been extreeeeeemely disappointing to see how poorly the integration of acquisitions / cost out has been handled over the last 12-16 months. I would sum up the previous management as great at deal making, crap at execution, big on spin, light on disclosure. This could be a great business if it was run well. In the sweet spot in terms of aging demographics and emerging health tech / consumables. It should almost be a "no brainer". But as things have turned out, I should have trusted the technical analysis and sold ages ago in Nov 2018. Apart from my ~50% negative position here, there is also the opportunity cost of not selling and re-investing elsewhere.
PGC Price at posting:
28.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)